VGI Health Technology Limited

NSX:VTL ISIN:AU0000152597

VGI Health Technology LimitedVGI Health Technology Limited (NSX:VTL) is an Australian public listed biotechnology company developing and commercialising novel dietary supplements and prescription medicines based on natural products (tocotrienols) which have wide therapeutic potential, including: Delayed Onset Muscle Soreness, muscle recovery, exercise endurance, Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic SteatoHepatitis (NASH), pancreatic cancer, hyperlipidaemia, hypertension and diabetes. VTL owns and controls patent and other intellectual property rights for novel approaches to non-invasively delivering tocotrienols directly to the target tissues. The Company has a product development program for evidence-based nutraceuticals and a clinical development program for prescription medicines.

  

News

VGI Health Technology Limited (NSX:VTL) Binding Sale Agreement of Subsidiary

🕔4/6/2022 8:50:00 AM 1673

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) US Divisional Patent to be Granted

🕔4/4/2022 7:44:00 AM 1555

VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the 'Transmucosal Delivery of Tocotrienols' to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) to Present at American Society for Nutrition Conference

🕔3/21/2022 8:57:00 AM 2274

VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Executes Agreement with Continuum Sciences LLC

🕔2/25/2022 9:02:00 AM 2375

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Dr Moon to present at Experimental Biology Conference

🕔2/23/2022 8:36:00 AM 2591

VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Term Sheet for Sale of Invictus BioPharma Group

🕔2/14/2022 9:09:00 AM 2195

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Approval of New Clinical Study Site

🕔2/9/2022 9:05:00 AM 1989

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned subsidiary, Invictus Ops Pty Ltd, has received Human Research Ethics Committee (HREC) approval from a Lead Ethics Committee Site, Bellberry Ltd, for a Phase II clinical study on Non-Alcoholic Fatty Liver Disease.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Hong Kong Patent Granted

🕔2/8/2022 8:57:00 AM 1969

VGI Health Technology Limited (NSX:VTL) is pleased to announce that the Hong Kong Patent Office has granted a patent for the Transmucosal Delivery of Tocotrienols to its wholly-owned subsidiary, Invictus Biotechnology Pty Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Contract with Resonance Health (ASX:RHT)

🕔1/25/2022 8:42:00 AM 13620

Invictus Ops Pty Ltd, a wholly owned subsidiary of NSX-listed VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has contracted Resonance Health Ltd (ASX:RHT) to provide liver-fat quantification services for its clinical study on a potential new treatment for Non-Alcoholic Steatohepatitis.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Nutraceutical Products Listed on Amazon

🕔1/20/2022 9:05:00 AM 1710

Invictus Nutraceuticals, Inc. (Florida, USA), a wholly owned subsidiary of VGI Health Technology Limited (NSX:VTL), is pleased to announce that both NE1-Elite(R) and NE1-Heart(R) are now available for sale on Amazon in the United States.

Read Full Article
###

23,551 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 359) (Last 30 Days: 1689) (Since Published: 23551) 

Company Data

    Headquarters
  • Level 45, Suite 03
    19-29 Martin Place
    Sydney, NSW, 2003
    Australia
  • Telephone
  • +61-2-8279-8908 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.vgiht.com

Company Reports

Quarterly Report

Social Media